Gene Expression Assay Classifies Diffuse Large B-Cell Lymphoma

Share this content:
Gene Expression Assay Classifies Diffuse Large B-Cell Lymphoma
Gene Expression Assay Classifies Diffuse Large B-Cell Lymphoma

THURSDAY, Oct. 19, 2017 (HealthDay News) -- A novel gene expression profiling diffuse large B-cell lymphoma (DLBCL) classifier, which evaluates the expression of 21 markers, is effective for classifying samples, according to a study published online Oct. 17 in the Journal of Molecular Diagnostics.

Victor Bobée, Pharm.D., from the University of Normandie in France, and colleagues developed a novel gene expression profiling DLBCL classifier based on reverse transcriptase multiplex ligation-dependent probe amplification, which simultaneously assesses the expression of 21 markers. The assay differentiates primary mediastinal B-cell lymphoma, activated B-cell-like, germinal center B-cell-like, and Epstein-Barr virus-positive DLBCLs.

The assay was trained using 70 paraffin-embedded biopsies and validated using more than 160 samples. The researchers found that reverse transcriptase multiplex ligation-dependent probe amplification classified 85 percent of the samples into the expected subtype compared with a reference classification established from Affymetrix U133+2 data; this compared favorably with current diagnostic methods. Even in archival paraffin-embedded tissues, this assay proved to be highly efficient for detecting the MYD88 L265P mutation.

"This reliable, rapid, and cost-effective method uses common instruments and reagents and could thus easily be implemented into routine diagnosis workflows, to improve the management of these aggressive tumors," the authors write.

Abstract/Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

NTproBNP Levels Are Significantly Lower in Blacks

NTproBNP Levels Are Significantly Lower in Blacks

Higher NTproBNP levels linked to increased risk of death; this association did not differ by race

Data May Weigh on Pros/Cons of Expanded Care Optometry

Data May Weigh on Pros/Cons of Expanded Care ...

Majority of residents in Kentucky, Oklahoma, New Mexico live within 30 minutes of ophthalmologist

Gaps Seen Between Hearing Loss, Receipt of Medical Evaluation, Tx

Gaps Seen Between Hearing Loss, Receipt of Medical ...

About 20.6 percent of those with hearing less than excellent/good had visited doctor for hearing issues

is free, fast, and customized just for you!

Already a member?

Sign In Now »